Skip to main content

Purification of Antibodies and Antibody Fragments Using CaptureSelect Affinity Resins

  • Protocol
  • First Online:
Monoclonal Antibodies

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1131))

Abstract

Ever since the introduction of bacterial derived surface proteins like protein A that demonstrate a natural binding reactivity towards antibodies, affinity chromatography has evolved into a well-established technology for the purification of antibodies and antibody fragments. Although high selectivity is provided by these types of affinity ligands, not all antibodies or antibody fragments are covered, which then forces the use of non-affinity-based processes that are less selective and often result in lower one-step purity and yield. To fill these gaps, we here describe a novel range of CaptureSelect affinity resins that enables immunoaffinity chromatography for a much broader range of antibody targets.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Ettre L (1993) Nomenclature for chromatography (IUPAC recommendations 1993). Pure Appl Chem 65(4):819–872

    Article  CAS  Google Scholar 

  2. Hage D (1999) Affinity chromatography: a review of clinical applications. Clin Chem 45(5):593–615

    CAS  PubMed  Google Scholar 

  3. Hjelm H, Hjelm K, Sjöquist J (1972) Protein A from Staphylococcus aureus: its isolation by affinity chromatography and its use as an immunosorbent for isolation of immunoglobulins. FEBS Lett 28(1):73–76

    Article  CAS  PubMed  Google Scholar 

  4. Shukla A et al (2007) Review, downstream processing of monoclonal antibodies: application of platform approaches. J Chromatogr B 848(1):28–39

    Article  CAS  Google Scholar 

  5. Hober S, Nord K, Linhult M (2007) Protein A chromatography for antibody purification. J Chromatogr B 848(1):40–47

    Article  CAS  Google Scholar 

  6. Grodzki A, Berenstein E (2010) Affinity chromatography: protein A and protein G sepharose. Methods Mol Biol 588:33–41

    Article  CAS  PubMed  Google Scholar 

  7. Nilson B et al (1992) Protein L from Peptostreptococcus magnus binds to the kappa light chain variable domain. J Biol Chem 267(4):2234–2239

    CAS  PubMed  Google Scholar 

  8. Hamers-Casterman C et al (1993) Naturally occurring antibodies devoid of light chains. Nature 363:446–448

    Article  CAS  PubMed  Google Scholar 

  9. Muyldermans S (2001) Single domain antibodies: current status. J Biotechnol 74(4):277–302

    CAS  PubMed  Google Scholar 

  10. van der Linden R et al (1999) Comparison of physical properties of llama VHH antibody fragments and mouse monoclonal antibodies. Biochim Biophys Acta 1431(1):37–46

    Article  PubMed  Google Scholar 

  11. Frenken L et al (2000) Isolation of antigen specific Llama VHH antibody fragments and their high level secretion by Saccharomyces cerevisiae. J Biotechnol 78(1):11–21

    Article  CAS  PubMed  Google Scholar 

  12. Kuroiwa Y et al (2009) Antigen-specific human polyclonal antibodies from hyperimmunized cattle. Nat Biotechnol 27(2):173–181

    Article  CAS  PubMed  Google Scholar 

  13. Reinhart D, Weik R, Kunert R (2012) Recombinant IgA production: single step affinity purification using camelid ligands and product characterization. J Immunol Methods 378(1–2):95–101

    Article  CAS  PubMed  Google Scholar 

  14. Sun Y et al (2012) Pilot production of recombinant human clotting factor IX from transgenic sow milk. J Chromatogr B 898:78–89

    Article  CAS  Google Scholar 

  15. Klooster R et al (2012) Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice. Brain 135(4):1081–1101

    Article  PubMed  Google Scholar 

  16. Hermans P et al (2012) Reinventing affinity tags: innovative technology designed for routine purification of C-terminal EPEA-tagged recombinant proteins. Genet Eng Biotechnol News 32(17):48–49

    Article  Google Scholar 

  17. Klooster R et al (2007) Improved anti-IgG and HSA affinity ligands: clinical application of VHH antibody technology. J Immunol Methods 324(1–2):1–12

    Article  CAS  PubMed  Google Scholar 

  18. Beyer T et al (2009) Serum-free production and purification of chimeric IgA antibodies. J Immunol Methods 346:26–27

    Article  CAS  PubMed  Google Scholar 

  19. Aitken R, Hosseini A, MacDuff R (1999) Structure and diversification of the bovine immunoglobulin repertoire. Vet Immunol Immunopathol 72(1–2):21–29

    Article  CAS  PubMed  Google Scholar 

  20. Low D, O’Leary R, Pujar N (2007) Future of antibody purification. J Chromatogr B 848(1):48–63

    Article  CAS  Google Scholar 

  21. Liu J et al (2009) Comparison of camelid antibody ligand to protein A for monoclonal antibody purification. Biopharm Int 22(9):35–43

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media, New York

About this protocol

Cite this protocol

Hermans, P., Adams, H., Detmers, F. (2014). Purification of Antibodies and Antibody Fragments Using CaptureSelect Affinity Resins. In: Ossipow, V., Fischer, N. (eds) Monoclonal Antibodies. Methods in Molecular Biology, vol 1131. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-992-5_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-992-5_19

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-991-8

  • Online ISBN: 978-1-62703-992-5

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics